Hessam Kakavand
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Long-Term Effects of COVID-19 2
-
- Acute Myocardial Infarction Research 3
- Antiplatelet Therapy and Cardiovascular Diseases 1
-
- Coronary Interventions and Diagnostics 2
- Lipoproteins and Cardiovascular Health 2
-
- Vitamin C and Antioxidants Research 1
- Co-authors
- Azita H. TalasazMaryam AghakouchakzadehBenjamín Van TassellSteven P. DunnParham SadeghipourDave L. DixonJames C. CoonsAlessandra Vecchié
- Journals
- Journal of Thrombosis and Haemostasis (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Journal of Cardiovascular Pharmacology (3 papers)
- Partner nations
- IranUnited StatesNetherlands
In The Last Decade
Hessam Kakavand
8 papers receiving 129 citations
Peers
Comparison fields: 5 of 50
- Infectious Diseases 67
- Neurology 50
- Internal Medicine 9
- Cardiology and Cardiovascular Medicine 32
- Pathology and Forensic Medicine 14
Countries citing papers authored by Hessam Kakavand
This map shows the geographic impact of Hessam Kakavand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hessam Kakavand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hessam Kakavand more than expected).
Fields of papers citing papers by Hessam Kakavand
This network shows the impact of papers produced by Hessam Kakavand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hessam Kakavand. The network helps show where Hessam Kakavand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hessam Kakavand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 19 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 16 | |
| 7 | 2020 | 32 | |
| 8 | 2020 | 45 |
About Hessam Kakavand
Hessam Kakavand is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Infectious Diseases, having authored 8 papers that have together received 132 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Acute Myocardial Infarction Research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Coronary Interventions and Diagnostics (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Long-Term Effects of COVID-19 (2 papers), Vitamin C and Antioxidants Research (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Infectious Diseases (67 citations), Neurology (50 citations) and Internal Medicine (9 citations). Hessam Kakavand has collaborated with scholars based in Iran, United States and Netherlands. Frequent co-authors include Azita H. Talasaz, Maryam Aghakouchakzadeh, Benjamín Van Tassell, Steven P. Dunn, Parham Sadeghipour, Dave L. Dixon, James C. Coons, Alessandra Vecchié, Giuseppe Biondi‐Zoccai and Enrico Ammirati. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Naunyn-Schmiedeberg s Archives of Pharmacology and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.